Supplementary file for “Association between trimethylamine N-oxide and adverse kidney outcomes, and overall mortality in type 2 diabetes mellitus”

Supplementary file for “Association between trimethylamine N-oxide and adverse kidney outcomes, and overall mortality in type 2 diabetes mellitus” Table S1. Cumulative probabilities of primary kidney outcome (dialysis and doubling of serum creatinine) and all-cause mortality among T2D patients over a 5-year period.Table S2A. Calibration of serum TMAO in predicting primary kidney outcomeTable S2B. Calibration of urine ACR in predicting primary kidney outcomeTable S2C. Calibration of eGFR in predicting primary kidney outcomeTable S3. Subgroup analysis of association between serum TMAO level and primary kidney outcome (dialysis and doubling of serum creatinine) risk in T2D patients

本文件为《氧化三甲胺（trimethylamine N-oxide，TMAO）与2型糖尿病患者不良肾脏结局及全因死亡率的关联》的补充材料，具体包含以下表格：
表S1：2型糖尿病患者5年内主要肾脏结局（透析及血清肌酐翻倍）与全因死亡率的累积概率
表S2A：血清氧化三甲胺（TMAO）预测主要肾脏结局的校准效能
表S2B：尿白蛋白肌酐比（urine ACR）预测主要肾脏结局的校准效能
表S2C：估算肾小球滤过率（eGFR）预测主要肾脏结局的校准效能
表S3：2型糖尿病患者血清氧化三甲胺（TMAO）水平与主要肾脏结局（透析及血清肌酐翻倍）风险关联的亚组分析